Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

American Journal of Human Genetics

Volumn 63, Issue 1, 1998, Pages 45-51

  Fodor, Flora H ^a   Weston, Ainsley ^a   Bleiweiss, Ira J ^a   McCurdy, Leslie D ^a   Walsh, Mary M ^a   Tartter, Paul I ^a   Brower, Steven T ^a   Eng, Christine M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; JEW; ONCOGENE; PATIENT COUNSELING; POPULATION RISK; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032231617     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301903     Document Type: Article

References (29)

1. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, et al (1997) The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Am J Hum Genet 60:505-514
2. Bignon YJ, Fonck Y, Chassagne M-C (1995) Histoprognostic grade in tumours from families with hereditary predisposition to breast cancer. Lancet 346:258
3. Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 48:232-242
4. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56:265-271
5. Egan KM, Newcomb PA, Longnecker MP, Trentham-Dietz A, Baron JA, Trichopoulos D, Stampfer MJ, et al (1996) Jewish religion and risk of breast cancer. Lancet 347:1645-1646
6. Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, Vincent-Salomon A, et al (1996) Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 56:471-474
7. FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, et al (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334:143-149
8. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1 mutation carriers: Breast Cancer Linkage Consortium. Lancet 343:692-695
9. Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King M-C (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8:399-404
10. Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, Lee MK, et al (1995) Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet 57:1284-1297
11. Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF, Ponder BAJ, UKCCCR Familial Ovarian Cancer Study Group (1996) Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. Am J Hum Genet 58:451-456
12. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, Rebbeck TR, Garber JE, Weber BL (1995) Assessment and counseling for women with a family history of breast cancer. JAMA 273:577-585
13. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, et al (1996) Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77:697-709
14. Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hample H, et al (1996) Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13:126-128
15. Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, et al (1996) The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 14:188-190
16. Offit K, Gilewski T, McGuire P, Schluger A, Hampel H, Brown K, Swensen J, et al (1996) Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 347: 1643-1645
17. Parker SL, Tong T, Bolden S, Wingo PA (1997) Cancer statistics, 1997. CA Cancer J Clin 47:5-27
18. Roa BB, Boyd AA, Volcik K, Richards CS (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185-187
19. Sepp R, Szabo I, Uda H, Sakamoto H (1994) Rapid techniques for DNA extraction from routinely processed archival tissue for use in PCR. J Clin Pathol 47:318-323
20. Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA 278:1242-1250
21. Shuber AP, Grondin VJ, Klinger KW (1995) A simplified procedure for developing multiplex PCRs. Genome Res 5: 488-493
22. Simard J, Tonin P, Durocher F, Morgan K, Rommens J, Gingras S, Samson C, et al (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 8:392-398
23. Stratton MR (1996) Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet 5: 1515-1519
24. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC, et al (1995) The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 11:198-200 (Erratum [1996] Nat Genet 12:110)
25. Struewing JP, Hartge P, Wacholder S, Mader SM, Berlin M, McAdams M, Timmerman MM, et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401-1408
26. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, et al (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12:333-337
27. Tonin P, Serova O, Lenoir G, Lynch H, Durocher F, Simard J, Morgan K, et al (1995) BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet 57:189
28. Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, et al (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2:1179-1183
29. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, et al (1994) Localization of breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090